Public Procurement of Medicines in Europe: Key Findings and Best Practices 

By Staff Writer

June 28, 2023

Experts in the Pharmacoeconomics Department recently conducted a study on the best practices in the public procurement of medicines. Commissioned by the European Commission, this study aims to improve access to medicines, affordability, availability, and more. 

Public procurement of medicines can improve access, foster competition, and address important policy objectives. This study mapped and analyzed PPM practices across 32 European countries, revealing some fascinating insights. 

 

 Findings include:

  • Different organizational forms of procurement, ranging from facility-based to centralized procurement.
  • Use of various procedures and techniques, including the Most Economically Advantageous Tender
  • Specific forms of procurement in the hospital sector
  • Impacts on policy objectives, such as access to medicines and environmental protection
  • Best practices for optimizing PPM in Europe

 

Discover the full report for a comprehensive understanding of PPM practices in Europe on the below link. Let’s work together to ensure affordable and accessible medicines for all! 

Reference url

Recent Posts

patient experience data
           

Transforming Brain Health Innovation with Patient Experience Data: Strategic Insights for Health Economics

🧠 Are we truly listening to patients when innovating for brain health?

Recent insights underscore the importance of patient experience data (PXD) in shaping research and regulatory decisions around neurological disorders. By embedding PXD at every stage of healthcare innovation, we can align new therapies with what truly matters to patients, enhancing outcomes and access.

Dive into the transformative potential of patient-centered data and how it’s setting a new standard in health economics and outcomes research.

#SyenzaNews #HealthcareInnovation #HealthEconomics #MarketAccess

thimerosal vaccine removal
      

Thimerosal Vaccine Removal: HHS Finalizes Decision

🩺 Is the removal of thimerosal from flu vaccines a step towards safer immunization or a move that could undermine public trust?

The recent decision by the U.S. Department of Health and Human Services to eliminate this mercury-based preservative has sparked a heated debate. While aiming to protect vulnerable populations, it raises questions about the impact on public perception and vaccine confidence.

Dive into the implications of this controversial policy shift and what it means for the future of vaccination practices.

#SyenzaNews #HealthcarePolicy #HealthEconomics

type 2 diabetes treatment
       

Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies

🤔 Are you up to date with the latest strategies for managing Type 2 Diabetes?

A recent comprehensive review jumps into the evolving landscape of Type 2 diabetes treatment, emphasizing individualized care through lifestyle modifications, effective medications, and emerging therapies. Discover how personalized approaches can not only improve health outcomes but also mitigate complications associated with this chronic condition.

Curious to learn more? Click through for insights that could transform your understanding of diabetes management!

#SyenzaNews #HealthcareInnovation #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.